KORU Medical Systems, Inc. Fundamental Analysis (NASDAQ: KRMD)
KORU Medical Systems, Inc. Fundamental Analysis (NASDAQ: KRMD)
KORU Medical Systems, Inc. (NASDAQ: KRMD) shows moderate financial fundamentals with a PE ratio of -212.43, profit margin of -1.78%, and ROE of -0.00%. The company generates $0.0B in annual revenue with strong year-over-year growth of 22.23%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 47.0/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze KRMD's fundamental strength across five key dimensions:
Efficiency Score
WeakKRMD struggles to generate sufficient returns from assets.
Valuation Score
ExcellentKRMD trades at attractive valuation levels.
Growth Score
ExcellentKRMD delivers strong and consistent growth momentum.
Financial Health Score
ExcellentKRMD maintains a strong and stable balance sheet.
Profitability Score
WeakKRMD struggles to sustain strong margins.
Key Financial Metrics
Is KRMD Expensive or Cheap?
P/E Ratio
KRMD trades at -212.43 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, KRMD's PEG of -1.14 indicates potential undervaluation.
Price to Book
The market values KORU Medical Systems, Inc. at 0.00 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 2256796617.25 times EBITDA. This signals the market has high growth expectations.
How Well Does KRMD Make Money?
Net Profit Margin
For every $100 in sales, KORU Medical Systems, Inc. keeps $-1.78 as profit after all expenses.
Operating Margin
Core operations generate -1.29 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-0.00 in profit for every $100 of shareholder equity.
ROA
KORU Medical Systems, Inc. generates $-0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
KORU Medical Systems, Inc. generates limited operating cash flow of $439.76K, signaling weaker underlying cash strength.
Free Cash Flow
KORU Medical Systems, Inc. generates weak or negative free cash flow of $-894.57K, restricting financial flexibility.
FCF Per Share
Each share generates $-0.02 in free cash annually.
FCF Yield
KRMD converts -0.53% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-212.43
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-1.14
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.00
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.73
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.16
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.97
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.00
vs 25 benchmark
ROA
Return on assets percentage
-0.00
vs 25 benchmark
ROCE
Return on capital employed
-0.00
vs 25 benchmark
How KRMD Stacks Against Its Sector Peers
| Metric | KRMD Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -212.43 | 31.30 | Better (Cheaper) |
| ROE | -0.00% | 487.00% | Weak |
| Net Margin | -1.78% | -1832.00% (disorted) | Weak |
| Debt/Equity | 0.16 | 0.10 | Weak (High Leverage) |
| Current Ratio | 2.97 | 5.74 | Strong Liquidity |
| ROA | -0.00% | -165.00% (disorted) | Weak |
KRMD outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews KORU Medical Systems, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
54.43%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-97.58%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
156.47%
Industry Style: Defensive, Growth, Innovation
High Growth